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ABSTRACT  
Background and Aims: This study aimed to develop a prediction model for identifying 
individuals at high absolute risk of esophageal squamous cell carcinoma (ESCC) for 
endoscopic screening at a curable stage based on readily identifiable risk factors.  
Methods: This was a nationwide Swedish population-based case-control study, including 
167 new cases of ESCC and 820 randomly selected control participants.  Odds ratios 
with 95% confidence intervals (CI) were assessed using multivariable unconditional 
logistic regression. The discriminative accuracy of the model was assessed by the area 
under the receiver operating characteristic curve (AUC) with leave-one-out cross-
validation. Models for projecting individuals’ absolute 5-year risk of ESCC were developed 
by incorporating the age- and sex-specific incidence rates and competing risk of death 
from other causes.  
Results: A model including the risk factors age, sex, tobacco smoking, alcohol 
overconsumption, education, duration of living with a partner, and place of residence 
during childhood generated an AUC of 0.81 (95% CI 0.77-0.84). A model based only on 
age, sex, tobacco smoking, and alcohol overconsumption obtained a similar AUC (0.79, 
95% CI 0.75-0.82). A 5-year follow-up of 355 men aged 70-74 years with over 35 years’ 
smoking and alcohol overconsumption history is needed to detect one ESCC case. The 
estimated individuals’ absolute 5-year risk of ESCC varied according to combinations of 
risk factors. 
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Conclusions: This “easy-to-use” risk prediction model showed a good discriminative 
accuracy and had the potential to identify individuals at high absolute risk of ESCC who 
might benefit from tailored endoscopic screening and surveillance.   
Keywords: Prediction model; esophageal neoplasm; risk assessment; early diagnosis.  
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INTRODUCTION 
Esophageal cancer is the 6th leading cause of cancer-related deaths globally. The two 
main histological types are esophageal squamous cell carcinoma (ESCC) and 
adenocarcinoma.1, 2  ESCC is a dominant cancer in Eastern countries and globally, and 
despite an increasing incidence of esophageal adenocarcinoma in Western countries, 
ESCC remains a major type of esophageal cancer also in these countries. In 2012, 
approximately 38,000 new cases of ESCC occurred in Europe, North America, and 
Oceania, accounting for around 60% of all cases of esophageal cancer in these regions.1 
ESCC is characterized by a poor prognosis with a population-based overall 5-year 
survival rate of less than 15% in Western countries, which has not improved much in 
recent years.3, 4 Most patients present with the cardinal symptoms, dysphagia and weight 
loss, which typically occur first at an advanced tumor stage, when the 5-year survival rate 
is low.5-7 Upper endoscopy may enable early detection of ESCC and other upper 
gastrointestinal cancers, but universal endoscopic screening is not justified, especially not 
in populations with low incidence rates of upper gastrointestinal cancers.8. A more 
feasible way may be to identify a limited group of individuals with high absolute risk of 
ESCC, who might benefit from tailored endoscopic screening and surveillance.2, 9 By 
combining readily identifiable risk factors, risk prediction modeling is a promising tool for 
selecting individuals with high absolute cancer risk.10-12 Yet, such prediction models have 
rarely been developed for ESCC, and none has been developed in a Western population. 
Using data from a high-quality nationwide population-based case-control study in Sweden, 
we aimed to develop a prediction model to estimate individuals’ absolute risk of ESCC in 
five years based on information on readily identifiable risk factors.  
6 
 
 
 
 
  
7 
 
METHODS 
Study design, participants, and data collection  
This study was based on data from a nationwide population-based case-control study in 
Sweden, which has been described elsewhere in detail.13 The study encompassed the 
whole Swedish population aged <80 years, born in Sweden, and living there between 
December 1, 1994, and December 31, 1997. The main reason for using this older case-
control study was its high internal validity, which will be difficult to repeat nowadays. A 
comprehensive organization was formed to ensure quick ascertainment of newly 
diagnosed cases. Patients were recruited by a local contact person at any of the 195 
(100%) participating hospital departments of general surgery, thoracic surgery, 
otorhinolaryngology, oncology, or pathology in Sweden and six regional tumor registries, 
to guarantee every potential case-patient was identified soon after diagnosis. Half of all 
newly diagnosed ESCC cases (n=228, born on even dates) were eligible, and 167 (73%) 
of these participated. Only half of all patients with ESCC were included because the 
incidence of ESCC was higher than that of adenocarcinoma and the case-control study 
mainly aimed to study risk factors for esophageal adenocarcinoma. The main reasons for 
non-participation were unwillingness (n=11, 5%) and physical or mental disorders or early 
death (n=50, 22%). All included patients underwent strict and uniform diagnostic routines, 
including endoscopy with histological confirmation of all tumors. Almost all (97%) tumor 
specimens were also re-examined by one experienced pathologist for increased 
histologic accuracy. Ambiguous cases were reviewed by a panel of researchers who 
utilized all available information. Eligible control subjects (n=1128) were randomly 
selected from the Registry of the Total Population in Sweden and were frequency-
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matched by age and sex to esophageal adenocarcinoma cases in the original case-
control study, and 820 participated (73% participation rate). Unwillingness was the most 
common reason for non-participation (n=210, 19%). Specially trained professional 
interviewers from the governmental agency Statistics Sweden conducted computer-aided 
face-to-face interviews of all case patients and control participants for the collection of a 
large number of potential risk factors and other relevant variables. The interviewers were 
kept unaware of the study hypotheses and were trained to treat all participants in an equal 
manner. Statistical power calculations were conducted, utilizing an α of 0.05 (two-sided), 
different exposure levers and odds ratios (ORs) of main risk factors, to show sufficient 
power. The study was approved by all regional ethical committees in Sweden, and 
informed consent was obtained from each participant before the interview.  
 
Model development  
The selection of candidate predictors of ESCC was based on literature review and 
associations found in the same case-control study. The nine-candidate variables were: 
age (<50, 50-59, 60-69, or 70-79 years), sex (male or female), tobacco smoking (never-
smokers, smokers for 1-20, 21-35, or >35 years), alcohol overconsumption (<70 or ≥70 
gram ethanol per week), formal education (≤10 or >10 years), duration of living with a 
partner (≤10 or >10 years), intake of fruit and vegetables (in tertiles as high, medium, or 
low), place of residence during childhood (rural or urban), and family history of 
esophageal or head and neck cancers in first-degree relatives (yes or no). A detailed 
description of the variable is available as a Supplementary File.  
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The final two panels of predictor variables were determined based on 2-step approach 
logistic regressions.14 In the first step, the four best-established risk factors for ESCC, i.e., 
age, sex, tobacco smoking, and alcohol overconsumption were included in the model 
without any selection procedure. These four variables were included in a simple prediction 
model. For the more extensive prediction model, selection of additional predictors was 
based on a stepwise backward selection approach whereby associations were losing 
statistical significance in the multivariable model at a predefined nominal significance 
level of 0.1. In the second step, predictors eliminated in the first step were re-entered into 
the multivariable model one by one to ensure that no omitted predictor statistically 
significantly improved the goodness of fit in a likelihood ratio test.14 Potential pairwise 
interactions between predictors were assessed in a preliminary model, indicating a 
statistically significant interaction between education and duration of living with a partner. 
A combination of these two factors was used to categorize participants into the following 
three groups: both education and partnership for >10 years, only education or partnership 
for >10 years, or both education and partnership for ≤10 years. 
   
Test of performance  
The discriminative ability of the models was assessed by the area under the receiver 
operating characteristic curve (AUC) and the Somers’ D statistic.15 The AUC measured 
the model’s ability to discriminate ESCC patients from control participants, and the 
Somers’ D statistic assessed the strength and direction of associations between predicted 
probabilities and observed responses.15 Because of the possible over-fitting of the model 
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when the performance was assessed with the same dataset as the one used to develop 
the model, re-testing of the performance of the models with leave-one-out cross-validation 
strategy was conducted.12 In this cross-validation process, the probability for each 
participant was predicted from a model ignoring this participant and used to calculate the 
unbiased AUC and Somers’ D statistic. 
 
Estimates of absolute 5-year risk 
The 5-year absolute risk of ESCC of an individual of a specific profile of risk factors and 
the corresponding 95% confidence intervals (CIs) were calculated based on: (1) the OR 
for the individual with the specific risk factors profile from the final logistic model, which 
was used as an approximation to the relative risk given the rare disease assumption, (2) 
the baseline age- and sex-specific incidence rate of ESCC in the Swedish population 
during the study period, (3) the estimated population attributable fraction (PAF) derived 
from the final logistic model, and (4) the age- and sex-specific mortality rate from reasons 
other than esophageal cancer in the population, to correct competing risk from 
mortality.10-12 The age- and sex-specific incidence rates of ESCC, mortality rates 
excluding esophageal cancer, and an example of estimating individual’s 5-year absolute 
risk are provided in the Supplementary File.  
The detailed algorithm of individual’s 5-year risk calculation with age(a), sex(s) and OR(r) 
was shown as:  
𝑃𝑃(𝑎𝑎, 𝑠𝑠, 𝑟𝑟) = 𝑏𝑏1𝑟𝑟
𝑏𝑏1𝑟𝑟+𝑏𝑏2
(1 − 𝑒𝑒−5(𝑏𝑏1𝑟𝑟+𝑏𝑏2))       [Formula 1] 
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where 𝑏𝑏1 are the age- and sex-specific baseline hazard rates of ESCC and 𝑏𝑏2 are the 
age- and sex-specific mortality rates from competing causes.  
The age- and sex-specific mortality rates excluding esophageal cancer ( 𝑏𝑏2 ) were 
calculated using the population mortality data from Statistics Sweden minus esophageal 
cancer specific mortality data from the NORDCAN database.16 The age- and sex-specific 
baseline hazard rates of ESCC (𝑏𝑏1) were calculated with Formula 2 below: 
𝑏𝑏1 = 𝐼𝐼𝐼𝐼𝑎𝑎𝑎𝑎 × (1 − 𝑃𝑃𝑃𝑃𝑃𝑃)       [Formula 2] 
where 𝐼𝐼𝐼𝐼𝑎𝑎𝑎𝑎 are incident rates for specific age and sex from the logistic regression, 𝑃𝑃𝑃𝑃𝑃𝑃 
are population attributable fractions which can be estimated by Formula 3: 
𝑃𝑃𝑃𝑃𝑃𝑃 = 1 − 1
𝑛𝑛
∑ (1
𝑟𝑟𝑖𝑖
)𝑛𝑛𝑖𝑖=1       [Formula 3] 
where 𝑛𝑛 is the number of total ESCC cases, 𝑟𝑟𝑖𝑖 is the OR for the 𝑖𝑖th cases estimated from 
the logistic regression model. All statistical analyses were conducted using the statistical 
software package SAS 9.4 for Windows (SAS Institute Inc., Cary, NC, USA). This study 
followed the Transparent Reporting of a multivariable prediction model for Individual 
Prognosis Or Diagnosis (TRIPOD) guidelines and checklist.17, 18 
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RESULTS 
Participants 
Characteristics of the 167 ESCC case patients and the 820 control participants are 
presented in Table 1. ESCC patients were more often smokers and had higher alcohol 
intake compared to the control participants.   
 
Predictor variables 
The full prediction model included six variables: age, sex, duration of tobacco smoking, 
alcohol overconsumption, the combined variable education and duration of living with a 
partner, and place of residence during childhood. The distribution of these variables 
among case patients and control participants and associations with ESCC risk are shown 
in Table 1. Tobacco smoking increased the risk of ESCC in a duration-response pattern. 
Alcohol overconsumption was associated with an increased risk of ESCC (adjusted OR 
3.67, 95% CI 2.39-5.62). The PAF combining all six predictors in the full model was 0.95. 
The simple prediction model included the four variables age, sex, duration of tobacco 
smoking, and alcohol overconsumption. The ORs for these factors in the simple model 
were similar to those in the full model (Table 1). The PAF of these four predictors was 
0.85.  
 
Model performance  
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The receiver operating characteristic curves for the two models are shown in Figure 1. 
The AUC statistics without cross-validation were 0.81 (95% CI 0.77-0.84) for the full 
model and 0.79 (95% CI 0.75-0.82) for the simple model (Table 2). The AUCs slightly 
decreased after leave-one-out cross-validation to 0.78 (95% CI 0.75-0.82) in the full 
model and 0.75 (95% CI 0.71-0.79) in the simple model (Table 2). 
 
Absolute 5-year risk of esophageal squamous cell carcinoma 
The projected absolute 5-year risks in individuals with different combinations of risk 
factors of ESCC in the simple model are illustrated in heat charts (Figure 2). In addition, 
Table 3 shows the estimated absolute 5-year risk of ESCC associated with selected 
combinations of risk factors. The estimated absolute 5-year risk of ESCC varied greatly 
across combinations of risk factors, ranging from 2.2/100,000 to 281.4/100,000 in men 
aged ≥50 years and from 0.4/100,000 to 126.6/100,000 in women aged ≥50 years (Figure 
2). The highest absolute risk (281.4/100,000) was found in men aged 70-74 years who 
had smoked for over 35 years and overconsumed alcohol. In this group, 355 individuals 
are needed to survey, e.g., by endoscopy or other screening or surveillance tools, to 
detect one case of ESCC within five years (Table 3, Supplementary Figure 1). Individuals’ 
5-year absolute risk of ESCC can be calculated by both the simple and the full model 
calculators in the Supplementary Files.  
 
 
14 
 
DISCUSSION 
This study developed a six-variable model and a four-variable model to predict individuals’ 
absolute risk of developing ESCC within the next five years based on information of 
readily identifiable risk factors. Both models had good performances regarding 
discriminative accuracy. The estimated absolute 5-year risk of ESCC varied greatly 
across combinations of risk factors and was heavily dependent on the risk factors age, 
sex, tobacco smoking, and alcohol overconsumption.  
To the best of our knowledge, this is the first study that developed a prediction model for 
the absolute risk of ESCC in a Western population. A few risk prediction models of ESCC 
or serious dysplasia of the esophagus have been developed in some Asian countries 
where ESCC seems to be associated with partly different risk factors than in Western 
populations. By pooling known risk factors (age, sex, tobacco smoking, and alcohol 
drinking) with genetic information (25 single nucleotide polymorphisms), a prediction 
model of ESCC from a Chinese population had an AUC of 0.71, which was lower than 
the AUCs in the presently developed models,19 and collecting and analysing genetic 
material might not be practical in the clinical setting. Using several potential risk factors 
(age, ethnicity, tobacco smoking, opium use, education, marital status, oral health, family 
history, tea temperature, and water source), a prediction model of ESCC based on a 
hospital-based case-control study in Iran generated an AUC of 0.77, which is similar to 
the four-variable model in the current study.20 A model for predicting the risk of severe 
esophageal dysplasia and higher-grade leisions has recently been developed from a 
cross-sectional study of a Chinese population.21 Using nine variables (age, family history 
of ESCC, cigarette smoking, body mass index ≤22, pesticide exposure, irregular eating 
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habits, intake of high-temperature foods, rapid ingestion of meals, and ingestion of 
leftover food during summer months) in participants aged >60 years, an AUC of 0.68 was 
indicated. With five variables (age, use of coal or wood as the main source of cooking 
fuel, body mass index ≤22, unexplained epigastric pain, and rapid ingestion of meals), 
the model for participants aged ≤60 had an AUC of 0.80. However, those models included 
ESCC symptoms (epigastric pain), which might limit their application in a screening 
program. Compared with the models developed in Asian populations, the model 
developed in the present study is the simplest, but still with the highest discrimination 
accuracy as measured by the AUC, and none of the previous studies estimated 
individuals’ absolute risk of ESCC.  
Strengths of this study include the use of data from a large and population-based study 
with high participation rates and excellent internal validity, based on random sampling of 
control participants, thorough histological ascertainment of all case-patients, and 
personal interviews with all participants. The cross-validation strategy used to evaluate 
the model performance partially counteracted over-fitting. The study also has limitations. 
Due to the case-control study design, as opposed to cohort studies, calibration of 
predicted absolute risk against observed risk was not possible.14 Moreover, given the low 
absolute incidence rate of ESCC (<2/100,000 person-year in 1994-1997 in Sweden),22 
the study contained too few control participants (n=820) for such analysis. Uncertainty in 
the recalling of past exposures is a threat with the case-control design. However, the risk 
factor profile was very different in patients with ESCC compared with the 189 patients 
with esophageal adenocarcinoma who also were interviewed as part of the same case-
control study, which argues against recall bias.13, 23-25  Although this study had sufficient 
16 
 
statistical power to detect associations between major risk factors and ESCC risk, there 
remains uncertainty in the precision of the predicted absolute risk of ESCC. Even though 
good internal validation was achieved, an over-estimation of the model was possible, and 
external validation in independent populations is needed before any clinical application 
can be recommended. 
Risk prediction models provide objective evidence-based estimates of individuals’ 
absolute risk of ESCC, and the information regarding the included risk factors is readily 
available and easily collected in clinical practice, public health settings, and external 
validation studies. The overall 5-year survival in ESCC is below 15%, and the survival 
rate is extremely low in patients diagnosed at late tumor stages.4 Detection at an early 
stage, through close follow-up in high-risk individuals, would probably reduce the mortality. 
Therefore, if confirmed in future research, the model presented in this study could help 
clinicians in their decision-making regarding possible tailored endoscopy surveillance.26 
Additionally, with the help of this model, public health care professionals and 
policymakers may estimate the future disease burden of ESCC in the population and plan 
appropriate prevention programs, including possible targeted screening programs for 
ESCC, in groups at high absolute risk. However, the thresholds for any screening or 
surveillance program need to be carefully determined, for which several aspects should 
be considered, including the absolute risk (incidence) in the target population, costs, and 
benefits and harm for the individuals. Notably, applying our four-variable simple model in 
the Swedish population in 1995-1997 suggested that 355 individuals are needed to be 
surveyed to detect one ESCC case in 5 years even among the highest risk category, 
which might not be cost-effective. However, the model may be more feasible in 
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populations with higher incidence rates, if externally validated, or with simpler and more 
affordable screening and surveillance tools in the future. Given the similarity in the 
etiology of ESCC, the present model might also be applicable for other Western countries, 
especially the Nordic countries. Choosing a risk threshold or evaluating the cost-
effectiveness is beyond the scope of this study. 
In summary, this study identified a model of good discriminative accuracy based on 
readily identifiable risk factors for predicting the absolute 5-year risk of ESCC in a Western 
population. The model needs to be validated in independent populations but has the 
potential for future use in identifying individuals at high absolute risk of ESCC who may 
benefit from tailored endoscopic surveillance for early tumor detection at a curable stage.  
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Table 1 Characteristics of controls and cases with esophageal squamous cell carcinoma from a Swedish case-control study with 
estimated odds ratios (ORs) with 95% confidence intervals (CIs) of esophageal squamous cell carcinoma  
Variables  Controls n (%) Cases n (%) Crude OR (95%CI) Adjusted OR (95%CI) a Adjusted OR (95%CI) b 
Total 820 (100)  167 (100)     
Age (years)           
<50 48 (6) 3 (2) 0.37 (0.11,1.22) 0.64 (0.18,2.31) 0.46 (0.13,1.60) 
50-59 161 (20) 35 (21) 1.28 (0.82,2.02) 1.66 (0.96,2.89) 1.28 (0.76,2.15) 
60-69 245 (30) 67 (40) 1.61 (1.10,2.36) 1.33 (0.86,2.06) 1.23 (0.80,1.88) 
70-79 366 (44) 62 (37) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
Sex           
Male 679 (83) 120 (72) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
Female 141 (17) 47 (28) 1.89 (1.29,2.77) 5.01 (3.07,8.18) 4.35 (2.70,7.00) 
Duration of smoking (years)           
Non-smokers 325 (40) 22 (13) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
1-20 155 (19) 21 (13) 2.00 (1.07,3.75) 2.09 (1.06,4.12) 2.17 (1.12,4.22) 
21-35 156 (19) 27 (16) 2.56 (1.41,4.63) 2.62 (1.36,5.05) 2.64 (1.40,4.98) 
>35 184 (22) 97 (58) 7.79 (4.74,12.80) 8.62 (4.91,15.14) 8.41 (4.87,14.52) 
Alcohol consumption (gram/week)         
≤70 642 (78) 89 (53) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
>70 178 (22) 78 (47) 3.16 (2.24,4.47) 3.67 (2.39,5.62) 3.24 (2.15,4.89) 
Education and duration of living with a 
partner (years)           
Education>10 and partnership>10 302 (37) 37 (22) 1.00 (reference) 1.00 (reference) - 
Education or partnership>10 462 (56) 110 (66) 1.94 (1.30,2.90) 2.10 (1.32,3.36) - 
Education≤10 and partnership≤10 56 (7) 20 (12) 2.92 (1.58,5.39) 3.10 (1.52,6.32) - 
Place of residence during childhood           
Urban 313 (38) 58 (35) 1.00 (reference ) 1.00 (reference ) - 
Rural 505 (62) 107 (65) 1.14 (0.81,1.62) 1.53 (1.01,2.33) - 
Population attributable fraction - - - 0.95 0.85 
a  Adjusted for all listed variables in the six-variable model; b Adjusted for the other three listed variables in the four-variable model.  
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Table 2 Performance of prediction models for individuals’ risk of esophageal squamous cell 
carcinoma  
  Original without cross-validation   Leave-one-out cross-validation  
Model AUC (95% CI)  Somers’ D   AUC (95% CI)  Somers’ D  
Six-variable model 0.81 (0.77,0.84) 0.61  0.78 (0.75,0.82) 0.57 
Four-variable model 0.79 (0.75,0.82) 0.57  0.75 (0.71,0.79) 0.50 
AUC: area under the receiver operating characteristic curve; CI: confidence interval. 
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Table 3 Estimated absolute 5-year risks of esophageal squamous cell carcinoma in a Swedish population associated with 
selected profiles of risk factor combinations from a model including age, sex, tobacco smoking, and alcohol overconsumption 
Profile 
no. Sex Age (years) Smoking (years) 
Alcohol 
overconsumption a 
Absolute 5-year 
risk, 1/100,000 
Number of individuals 
needed to survey to 
detect one case 
1 Male 50-54 Non-smokers No 2.2 46,440 
2 Male 50-54 1-20 No 4.7 21,391 
3 Male 50-54 21-35 No 5.7 17,618 
4 Male 50-54 >35 No 18.1 5,521 
5 Male 50-54 >35 Yes 58.7 1,702 
6 Male 60-64 21-35 No 19.5 5,137 
7 Male 60-64 >35 No 62.1 1,610 
8 Male 60-64 >35 Yes 201.3 497 
9 Male 70-74 Non-smokers No 10.3 9,683 
10 Male 70-74 >35 No 86.8 1,152 
11 Male 70-74 >35 Yes 281.4 355 
12 Female 50-54 1-20 Yes 2.8 35,521   
13 Female 60-64 >35 Yes 45.4 2,201 
14 Female 70-74 Non-smokers No 3.8 26,150 
15 Female 70-74 >35 Yes 104.3 959 
a Alcohol overconsumption was defined as alcohol consumption >70 gram/week. 
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FIGURE LEGENDS: 
Figure 1: The receiver operating characteristic curves based on a six-variable full 
model and a four-variable simple model. AUC= the area under the receiver operating 
characteristic curve. 
Figure 2: Absolute 5-year risks of esophageal squamous cell carcinoma per 100,000 
person-years, estimated from the four-variable simple model individuals aged 50 years 
or above. 
 
 
 
